QR code

Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Importance: Individuals with schizophrenia are at higher risk for severe COVID-19 illness and severe breakthrough infection following vaccination. It is unclear whether immune response to vaccination differs in this population. Objective: To assess whether anti-SARS-CoV-2 spike antibody titers after...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2024-07-01
Reeks:Brain, Behavior, & Immunity - Health
Onderwerpen:
Schizophrenia
Schizoaffective disorder
COVID-19
mRNA vaccine
Immunogenicity
Antibody response
Online toegang:http://www.sciencedirect.com/science/article/pii/S2666354624000802
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items